Literature DB >> 16254651

[Epidemiological and clinical outlook of chronic Chagas' heart disease in Mexico].

Justo Sierra-Johnson1, Amonario Olivera-Mar, Víctor M Monteón-Padilla, Pedro A Reyes, Maite Vallejo.   

Abstract

OBJECTIVE: To compare the epidemiological and clinical characteristics of chronic Chagas' heart disease to other dilated cardiomyopathies.
METHODS: A study comprising 128 patients from a heart disease center was carried out from 1993 to 2003. Of them, 51 (40%) were Trypasonoma cruzi positive. Epidemiological data was obtained through interviews and clinical and serological data from health services. Statistic analysis was conducted using the Chi-square, Fischer, Mann-Whitney or Students' t-test as well as multivariate analysis.
RESULTS: Chronic Chagas' disease patients were older (55+/-10 years old) than those patients with cardiopathy (42+/-17 years old). Most of them were born in rural areas (90% vs 68%), lived in poor (75% vs 16%), crowded households (45% vs 20%), together with domestic animals (71% vs 61%) and were aware of the Chagas' vector (73% vs 25%). Rhythm and conduction ECG abnormalities as well as permanent pacemaker were common among Chagas' patients (84% vs 55%, 78% vs 64% and 24% vs 10%, respectively). Congestive heart failure was more frequent among cardiomiopathy patients (88% vs 71%). Both groups had abnormal myocardial perfusion with normal epicardial arteries. Comorbidities were more frequent in cardiomiopathy patients than in chronic Chagas' disease patient (two cases only).
CONCLUSIONS: Chagas' disease is the most common cause of dilated cardiomiopathy in the study hospital. Due to its regional distribution in Mexico, it deserves special attention and control programs proven to be effective in other countries.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254651     DOI: 10.1590/s0034-89102005000500009

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  5 in total

1.  A Critical Assessment of Officially Reported Chagas Disease Surveillance Data in Mexico.

Authors:  Ellen M Shelly; Rodolfo Acuna-Soto; Kacey C Ernst; Charles R Sterling; Heidi E Brown
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

2.  Chagas Heart Failure in Patients from Latin America.

Authors:  Reinaldo B Bestetti
Journal:  Card Fail Rev       Date:  2016-11

3.  Prevalence of Chagas heart disease in dilated cardiomyopathy.

Authors:  Héctor González-Zambrano; Gerardo Amaya-Tapia; María C Franco-Ramos; Oscar J López León-Murguía
Journal:  Arch Cardiol Mex       Date:  2020-10-20

4.  Seroprevalence survey of American trypanosomiasis in Central Valley of Toluca.

Authors:  Israel A Quijano-Hernández; Alejandro Castro-Barcena; Alberto Barbabosa-Pliego; Laucel Ochoa-García; Javier Del Ángel-Caraza; Juan C Vázquez-Chagoyán
Journal:  ScientificWorldJournal       Date:  2012-04-30

Review 5.  An unfolding tragedy of Chagas disease in North America.

Authors:  Peter J Hotez; Eric Dumonteil; Miguel Betancourt Cravioto; Maria Elena Bottazzi; Roberto Tapia-Conyer; Sheba Meymandi; Unni Karunakara; Isabela Ribeiro; Rachel M Cohen; Bernard Pecoul
Journal:  PLoS Negl Trop Dis       Date:  2013-10-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.